NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 28th March 2011 The ROADMAP trial found olmesartan delayed the onset of microalbuminuria in patients with type 2 diabetes and normoalbuminuria. While this disease-oriented outcome (DOO) suggested a potential benefit […]
Category Archives: Cardiovascular disease
NPC Archive Item: More improvement needed in the drug management of heart failure
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 8th February 2011 The National Heart Failure audit 2010 confirms the improvements suggested last year in the use of key treatments for heart failure, such as ACE inhibitors and beta […]
NPC Archive Item: Does eplerenone▼ have a role in mild heart failure?
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 13th January 2011 The EMPHASIS-HF study found that adding eplerenone▼ to recommended therapy for heart failure (HF) with left ventricular systolic dysfunction (LVSD) reduced the risk of a composite […]
NPC Archive Item: New from NICE: Important changes in the use of clopidogrel and modified-release dipyridamole
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 17 May 2011 Clopidogrel* alone is now recommended by NICE with no limits on duration of treatment in people who have had an ischaemic stroke. Modified-release (MR) dipyridamole plus aspirin […]
NPC Archive Item: Reducing treatment dose errors with low molecular weight heparins
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 06 September 2010 Introduction In July 2010, the National Patient Safety Agency (NPSA) issued its Rapid Response Report: Reducing treatment dose errors with low molecular weight heparins (LMWHs)1, making […]
NPC Archive Item: May Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 26 May 2010 The MHRA and CHM have published the May edition of Drug Safety Update This edition includes […]
NPC Archive Item: What is the place in therapy of simvastatin 80mg in the light of recent MHRA guidance?
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 25 May 2010 The May edition of Drug Safety Update includes an article advising healthcare professionals that the product information for simvastatin has been updated to highlight the increased […]
NPC Archive Item: Do statins have mortality benefits in heart failure?
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 14 May 2010 This meta-analysis found that while statins reduced hospitalisation for worsening heart failure, they did not significantly reduce all-cause mortality or cardiovascular mortality in people with heart […]
NPC Archive Item: ‘Gold standard’ clinic BP measurements by trained staff are closer to ambulatory BP measurements than clinic measurements by doctors
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 27 April 2010 This Australian observational study found that blood pressure (BP) measured in clinic by specialist staff using immaculate technique was higher than ambulatory BP values by an […]
NPC Archive Item: A key message on intensive blood-pressure control in type 2 diabetes mellitus from ACCORD
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 20 April 2010 The ACCORD blood-pressure (BP) study conducted in patients with type 2 diabetes at high risk for cardiovascular (CV) disease concluded that intensive BP control to a target […]